DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $305,526,598 | +3.5% | 1,231,466 | +0.1% | 0.26% | +5.8% |
| Q2 2023 | $295,325,649 | -4.6% | 1,230,524 | +0.2% | 0.24% | -9.7% |
| Q1 2023 | $309,513,927 | -1.3% | 1,228,035 | +3.9% | 0.27% | -6.6% |
| Q4 2022 | $313,569,502 | +21.4% | 1,181,393 | +18.2% | 0.29% | +10.3% |
| Q3 2022 | $258,194,000 | +3.8% | 999,616 | +1.9% | 0.26% | +7.4% |
| Q2 2022 | $248,689,000 | -10.3% | 980,938 | +3.8% | 0.24% | +3.8% |
| Q1 2022 | $277,209,000 | -10.3% | 945,037 | +0.6% | 0.23% | -6.0% |
| Q4 2021 | $308,989,000 | +8.7% | 939,142 | +0.5% | 0.25% | -2.4% |
| Q3 2021 | $284,378,000 | +16.7% | 934,100 | +2.9% | 0.26% | +14.9% |
| Q2 2021 | $243,647,000 | +30.4% | 907,908 | +9.4% | 0.22% | +17.5% |
| Q1 2021 | $186,862,000 | +7.7% | 830,199 | +6.2% | 0.19% | -0.5% |
| Q4 2020 | $173,575,000 | +6.3% | 781,374 | +3.1% | 0.19% | -6.9% |
| Q3 2020 | $163,258,000 | +23.9% | 758,173 | +1.8% | 0.20% | +15.3% |
| Q2 2020 | $131,727,000 | +35.0% | 744,931 | +5.6% | 0.18% | +14.2% |
| Q1 2020 | $97,595,000 | +1.7% | 705,110 | +12.7% | 0.16% | +27.0% |
| Q4 2019 | $95,994,000 | +13.3% | 625,444 | +6.7% | 0.12% | +3.4% |
| Q3 2019 | $84,697,000 | -3.8% | 586,420 | -4.8% | 0.12% | -7.1% |
| Q2 2019 | $88,033,000 | +20.6% | 615,960 | +11.4% | 0.13% | +14.4% |
| Q1 2019 | $72,993,000 | +30.6% | 552,889 | +2.0% | 0.11% | +14.4% |
| Q4 2018 | $55,892,000 | -3.1% | 542,012 | +2.1% | 0.10% | +9.0% |
| Q3 2018 | $57,689,000 | +24.0% | 530,908 | +12.6% | 0.09% | +14.1% |
| Q2 2018 | $46,528,000 | +2.3% | 471,505 | +1.5% | 0.08% | -4.9% |
| Q1 2018 | $45,493,000 | +13.6% | 464,637 | +7.6% | 0.08% | +10.8% |
| Q4 2017 | $40,063,000 | +19.7% | 431,621 | +10.6% | 0.07% | +10.4% |
| Q3 2017 | $33,479,000 | -2.7% | 390,283 | -4.3% | 0.07% | -9.5% |
| Q2 2017 | $34,419,000 | -0.4% | 407,855 | +1.0% | 0.07% | -7.5% |
| Q1 2017 | $34,548,000 | +23.3% | 403,928 | +12.2% | 0.08% | +11.1% |
| Q4 2016 | $28,029,000 | +11.6% | 360,077 | +12.3% | 0.07% | +4.3% |
| Q3 2016 | $25,124,000 | +5.6% | 320,498 | +36.0% | 0.07% | -8.0% |
| Q2 2016 | $23,796,000 | +10.9% | 235,608 | +4.1% | 0.08% | +2.7% |
| Q1 2016 | $21,466,000 | +1.7% | 226,287 | -0.4% | 0.07% | -3.9% |
| Q4 2015 | $21,112,000 | +2.0% | 227,302 | -6.4% | 0.08% | -9.5% |
| Q3 2015 | $20,700,000 | +0.5% | 242,930 | +1.0% | 0.08% | +6.3% |
| Q2 2015 | $20,588,000 | +18.5% | 240,540 | +17.6% | 0.08% | +3.9% |
| Q1 2015 | $17,369,000 | +24.3% | 204,584 | +25.5% | 0.08% | +11.8% |
| Q4 2014 | $13,971,000 | +10.2% | 163,003 | -2.3% | 0.07% | -6.8% |
| Q3 2014 | $12,675,000 | -12.0% | 166,816 | -8.8% | 0.07% | -18.0% |
| Q2 2014 | $14,396,000 | +14.3% | 182,856 | +8.9% | 0.09% | +3.5% |
| Q1 2014 | $12,598,000 | -0.3% | 167,978 | +2.7% | 0.09% | -9.5% |
| Q4 2013 | $12,630,000 | +0.8% | 163,605 | -9.5% | 0.10% | -12.0% |
| Q3 2013 | $12,527,000 | +17.8% | 180,716 | +7.6% | 0.11% | +8.0% |
| Q2 2013 | $10,632,000 | – | 167,968 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |